Avalanche Continues Uptrend Despite Overbought Risk
Avalanche (AVAX) continued its recovery this week, ending at $8.01 with an 8% gain.
The uptrend is attributed to recent institutional developments, including major product upgrades and adoption momentum.
However, the long-term price structure for Avalanche remains negative, leaving investors cautious as they prepare for further volatility in the coming days.